CLINICALLY RELEVANT INTERACTIONS WITH GLYCOSIDES

被引:0
|
作者
BODEM, G
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1739 / 1742
页数:4
相关论文
共 50 条
  • [1] Valerian: No evidence for Clinically Relevant interactions
    Kelber, O.
    Nieber, K.
    Kraft, K.
    PLANTA MEDICA, 2012, 78 (11) : 1138 - 1139
  • [2] Valerian: No Evidence for Clinically Relevant Interactions
    Kelber, Olaf
    Nieber, Karen
    Kraft, Karin
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
  • [3] Clinically relevant new drug interactions
    Fuhr, U
    MEDIZINISCHE KLINIK, 1999, 94 (02) : 120 - 124
  • [4] Clinically relevant new drug interactions
    Fuhr, U
    MEDIZINISCHE KLINIK, 2000, 95 : 18 - 22
  • [5] CLINICALLY RELEVANT DRUG-INTERACTIONS
    HENGSTMANN, JH
    MEDIZINISCHE WELT, 1981, 32 (07): : 232 - 233
  • [6] Clinically relevant drug interactions in anxiety disorders
    Muscatello, Maria Rosaria
    Spina, Edoardo
    Bandelow, Borwin
    Baldwin, David S.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2012, 27 (03) : 239 - 253
  • [7] Antidepressants: Clinically Relevant Drug Interactions to Be Considered
    Schellander, Rene
    Donnerer, Josef
    PHARMACOLOGY, 2010, 86 (04) : 203 - 215
  • [8] WHICH DRUG-INTERACTIONS ARE CLINICALLY RELEVANT
    MEYER, UA
    INTERNIST, 1979, 20 (05): : 251 - 256
  • [9] Pulmonary and cardiac drugs: clinically relevant interactions
    Olschewski, H.
    Canepa, M.
    Kovacs, G.
    HERZ, 2019, 44 (06) : 517 - 521
  • [10] Clinically relevant drug interactions with antiepileptic drugs
    Perucca, E
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (03) : 246 - 255